Cooperative Agreement 72011519CA00001

The $3,595,735 Cooperative Agreement awarded by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program aims to reduce the burden of tuberculosis (TB), particularly drug-resistant TB, in the Central Asia region over a 5-year period. The award recipient, Koninklijke Nederlandse Centrale Vereniging Tot Bestrijding DER Tuberculose (Kncv), a Dutch non-profit organization specializing in TB elimination and healthcare...

The Health Services Kentucky Cabinet For was awarded a $438,214 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Project Grants and Cooperative Agreements for Tuberculosis Control Programs (CFDA 93.116). The purpose of this five-year grant, with a performance period from January 1, 2025 to December 31, 2029, is to ensure core tuberculosis (TB) program activities are implemented to meet the needs of TB prevention, control, and elimination throughout the...

This $758,488 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to investigate the emergence and transmission of multidrug-resistant tuberculosis (MDR-TB) in the Republic of Moldova. The key products and services to be delivered through this 5-year grant include: Comparing the evolution and expansion of Beijing and Ural MTB lineages in Moldova since 2010, using over 2,000 MTB...

This federal Cooperative Agreement award, provided by the Centers for Disease Control and Prevention (CDC) under the Project Grants and Cooperative Agreements for Tuberculosis Control Programs (CFDA 93.116), supports the North Dakota Department of Health and Human Services (NDDHHS) in implementing a comprehensive strategy to combat tuberculosis (TB) in North Dakota. The $171,602 project aims to reduce TB incidence by focusing on early identification and treatment of both active TB cases and...

<p>The U.S. Department of State's Bureau of Counterterrorism awarded a $790,123 Project Grant (CFDA 19.701 - Global Counterterrorism Programs) to UNICEF's PPD Division to support efforts to build national and local government and/or civil society capacity in Kyrgyzstan and Tajikistan. The grant aims to support the implementation of community-led return and reintegration programs for returning families. The award period runs from September 26, 2023 to September 26, 2025.</p>

The Department of State Bureau of South and Central Asian Affairs awarded a $119,975 cooperative agreement to Saferworld to strengthen civic engagement of young women and men in Kyrgyzstan from October 1, 2021 to May 31, 2022. This funding supports the Public Diplomacy Programs (CFDA 19.040) objective to inform and influence foreign publics and expand relationships between people and the United States. Specifically, Saferworld will deliver programs and services under this cooperative agreement...

The Tropical Disease Foundation Inc. (TDF) has been awarded a $6,480,574 Cooperative Agreement by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) federal grant program. The purpose of this 5-year award, running from January 2025 to January 2030, is to control and prevent the spread of tuberculosis in the Visayas and Mindanao regions of the Philippines. As a foreign-owned non-profit organization specializing in...

The State of Georgia Department of Public Health (GDPH) received a $217,191 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The purpose of this award is to reduce tuberculosis (TB) morbidity and mortality in Georgia by preventing transmission, preventing progression from latent TB infection to active disease, and strengthening laboratory capacity for timely and reliable TB...

This $287,878,180 Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) federal grant program is intended to scale up and improve management of drug-resistant tuberculosis (DR-TB) in USAID-supported countries. The award will focus on expanding access to high-quality DR-TB treatment services and providing specialized technical assistance to enhance DR-TB program quality at the country level. Key...

The State of Alaska Department of Health has been awarded a $518,114 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based grant program (CFDA 93.940). The award will support the Alaska Division of Public Health Tuberculosis Elimination and Laboratory Program in its efforts to eliminate tuberculosis in Alaska. Key activities include identifying and treating individuals with active TB disease and TB infection,...